What conditions does LB Pharmaceuticals Inc. run trials for?

In our tracked recruiting trials, LB Pharmaceuticals Inc. sponsors trials for Schizophrenia, Bipolar I Disorder, Bipolar disorder.

Clinical trials sponsored by LB Pharmaceuticals Inc.

Recruiting trials

Conditions studied

Phase 2 1Phase 3 2

52-week Open Label Safety-Tolerability Study
NCT07369154 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 23 locations
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
NCT07494305 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 26 locations
Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
NCT07363577 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 13 locations

LB Pharmaceuticals Inc. is the lead sponsor of 3 recruiting trials.

No. For the full record, search ClinicalTrials.gov.